SScientific Reports2d agoClinical benefit of palbociclib retreatment after abemaciclib exposure in hormone receptor positive, HER2 negative metastatic breast cancerMuhan Yu·Masayuki Otsuka·Mamoru Takada·Daisuke Takabatake·Mina Takahashi·Mariko Kochi·Maya Uno·Midori Kondo·Takeshi Nagashima·Hiroshi Fujimoto·Junta Sakakibara·Ryotaro Teranaka·Kenjiro Aogi·Michiko YamashitaRead at Scientific ReportsTagsAdvanced Breast Cancer TherapiesPulmonary and Respiratory Medicine